BIOXCEL SHAREHOLDER ALERT CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF 100000 of Lead Plaintiff Deadline in Class Action Lawsuit Against BioXcel Therapeutics Inc BTAI

NEW ORLEANS, July 18, 2023 (GLOBE NEWSWIRE) — ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 5, 2023 to file lead plaintiff applications in a securities class action lawsuit against BioXcel Therapeutics, Inc. (NasdaqCM: BTAI), if they purchased the Company’s securities between December 15, 2021…Read More

Leave a Reply

Your email address will not be published. Required fields are marked *